VRAY ViewRay, Inc.

3.91-0.35 (-8.22%)
Close: August 23, 2019

3.920.01 (+0.33%)
Pre-market

Quote

Previous Close
$3.91
Day Range
$3.86-$4.46
52 Week Range
$2.76-$10.73
Volume
2,306,178
Avg Volume
2,927,829
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$385.06M
Enterprise Value (EV)
$307.46M
PE Ratio
-
EV/EBITDA
-4.29
Price/Sales
5.18
Price/Book
2.30
PEG Ratio
-

Financials

Revenue
$80.96M
Gross Profit
$6.60M
EBITDA
-$71.66M
EPS, ttm
-$1.22
Profit Margin
-
Revenue/Employee
$366.34K
Next Earnings Date
11/11/2019 (78 days)
Debt to Equity
33%
Debt
$89.83M
Cash
$167.43M
Net Debt
-

Performance

Beta
1.94
200 Day Moving Avg
$7.56
50 Day Moving Avg
$7.72
52 Week Change
-60.38%
YTD Change
-44.74%
1 Month Change
-58.80%
3 Month Change
-55.01%
6 Month Change
-52.66%
1 Year Change
-60.38%
2 Year Change
29.07%
5 Year Change
63.40%

Share Count

Shares Outstanding
98.5M
Float
72.5M
Restricted Shares
26.0M
Restricted Shares, %
26.40%

ViewRay, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Scott William Drake

Website: http://www.viewray.com

Description: ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Employees: 221